Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 8:11 p.m.

    📋 Century Therapeutics, Inc. (IPSC) - Financial Results

    Filing Date: 2022-05-16

    Accepted: 2022-05-16 07:30:15

    Event Type: Financial Results

    Event Details:

    Century Therapeutics Inc (IPSC) Reports Q2 2022 Financial Results Century Therapeutics Inc (IPSC) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: 1058
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 126039
      • “We are off to a strong start in 2022, which we expect will be a transformational year for Century as we transition into a clinical
      • stage organization,” said Lalo Flores, Chief Executive Officer, Century Therapeutics. “Looking ahead, we remain on track to submit our first IND application for our lead program, CNTY
      • year, with the Phase 1 ELiPSE

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 4.24K 5.28K $-1.03K -19.58%
    Current Assets Property Equipment Net 64.68K 57.97K $6.71K +11.58%
    Current Assets Operating Lease Right Of Use Assets 11.67K 11.85K $-184.00 -1.55%
    Current Liabilities Accounts Payable 9.89K 7.60K $2.30K +30.24%
    Current Liabilities Other Long Term Liabilities 1.47K 2.02K $-550.00 -27.23%
    Operating Expenses Loss From Operations 37.44K 18.06K $19.37K +107.26%
    Operating Expenses Interest Expense 314.00 314.00 $0.00 +0.00%
    Operating Expenses Other Income Net 253.00 28.00 $225.00 +803.57%
    Operating Expenses Net Loss 37.51K 18.35K $19.16K +104.45%
    Operating Expenses Net Loss Per Share 0.66 2.39 $-1.73 -72.38%
    Prepaid Expenses and Other Current Assets 4.24K 5.28K $-1.03K -19.58%
    Property and Equipment, Net 64.68K 57.97K $6.71K +11.58%
    Accounts Payable 9.89K 7.60K $2.30K +30.24%
    Loss from Operations 37.44K 18.06K $19.37K +107.26%
    Interest Expense 314.00 314.00 $0.00 +0.00%
    Other Income, Net 253.00 28.00 $225.00 +803.57%
    Net Loss 37.51K 18.35K $19.16K +104.45%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Century Therapeutics Inc
    • CIK: 0001850119
    • Ticker Symbol: IPSC
    • Period End Date: 2022-05-16
    • Document Type: 8-K

Search

News categories